Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- CWRU faculty members win National Science Foundation CAREER grants
- Weatherhead School’s Scott Shane comments on proposed plan to bring secondary market to equity crowdfunding
- Bioethics’ Insoo Hyun weighs in on “14-day rule”
- History’s Peter Shulman wins award for article on postal history
- How will the Republican National Convention impact Cleveland? Find out at next Baker-Nord Center event